Department of Neurosciences CEDD DMPK, GlaxoSmithKline Medicines Research Centre, Via Fleming 4, 37135 Verona, Italy.
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Jan 1;878(1):21-8. doi: 10.1016/j.jchromb.2009.11.009.
Amphetamines are a group of sympathomimetic drugs that exhibit strong central nervous system stimulant effects. D-Amphetamine ((+)-alpha-methylphenetylamine) is the parent drug in this class to which all others are structurally related. In drug discovery, d-amphetamine is extensively used either for the exploration of novel mechanisms involving the catecholaminergic system, or for the validation of new behavioural animal models. Due to this extensive use of D-amphetamine in drug research and its interest in toxicologic-forensic investigation, a specific and high-throughput method, with minimal sample preparation, is necessary for routine analysis of D-amphetamine in biological samples. We propose here a sensitive, specific and high-throughput bioanalytical method for the quantitative determination of D-amphetamine in rat blood using MS(3) scan mode on a hybrid triple quadrupole-linear ion trap mass spectrometer (LC-MS/MS/MS). Blood samples, following dilution with water, were prepared by fully automated protein precipitation with acetonitrile containing an internal standard. The chromatographic separation was achieved on a Waters XTerra C18 column (2.1mm x 30mm, 3.5microm) using gradient elution at a flow rate of 1.0mL/min over a 2min run time. An Applied Biosystems API4000 QTRAP mass spectrometer equipped with turbo ion-spray ionization source was operated simultaneously in MS(3) scan mode for the d-amphetamine and in multiple reaction monitoring (MRM) for the internal standard. The MS/MS/MS ion transition monitored was m/z 136.1-->119.1-->91.1 for the quantitation of d-amphetamine and for the internal standard (rolipram) the MS/MS ion transition monitored was m/z 276.1-->208.2. The linear dynamic range was established over the concentration range 0.5-1000ng/mL (r(2)=0.9991). The method was rugged and sensitive with a lower limit of quantification (LLOQ) of 0.5ng/mL. All the validation data, such as accuracy, precision, and inter-day repeatability, were within the required limits. This method was successfully applied to evaluate the pharmacokinetics of d-amphetamine in rat. On a more general extent, this work demonstrated that the selectivity of the fragmentation pathway (MS(3)) can be used as alternative approach to significantly improve detection capability in complex situation (e.g., small molecules in complex matrices) rather than increasing time for sample preparation and chromatographic separation.
苯丙胺类药物是一组具有强烈中枢神经系统兴奋剂作用的拟交感胺药物。D-苯丙胺((+)-α-甲基苯丙胺)是此类药物的母体药物,所有其他药物均与其结构相关。在药物发现中,d-苯丙胺被广泛用于探索涉及儿茶酚胺能系统的新机制,或用于验证新的行为动物模型。由于 D-苯丙胺在药物研究中的广泛应用及其在毒理学-法医学调查中的兴趣,因此需要一种特殊的高通量方法,该方法需要最小的样品制备,用于对生物样品中的 D-苯丙胺进行常规分析。我们在这里提出了一种灵敏,特异和高通量的生物分析方法,用于使用混合三重四极杆-线性离子阱质谱仪(LC-MS/MS/MS)的 MS(3)扫描模式定量测定大鼠血液中的 D-苯丙胺。用水稀释血液样品后,通过使用含内标的乙腈进行全自动蛋白质沉淀来制备。在 2 分钟的运行时间内,以 1.0mL/min 的流速在 Waters XTerra C18 柱(2.1mm x 30mm,3.5μm)上实现色谱分离。配备涡轮离子喷雾电离源的Applied Biosystems API4000 QTRAP 质谱仪同时以 MS(3)扫描模式用于 d-苯丙胺,并以多重反应监测(MRM)用于内标。用于定量 d-苯丙胺和内标(罗利普兰)的 MS/MS/MS 离子跃迁监测为 m/z 136.1→119.1→91.1。线性动态范围在 0.5-1000ng/mL 的浓度范围内建立(r(2)=0.9991)。该方法具有坚固性和灵敏性,定量下限(LLOQ)为 0.5ng/mL。所有验证数据,例如准确性,精密度和日间重复性,均在要求范围内。该方法成功地应用于评估大鼠中 d-苯丙胺的药代动力学。更广泛地说,这项工作表明,碎片途径(MS(3))的选择性可作为在复杂情况下(例如,复杂基质中的小分子)显着提高检测能力的替代方法,而不是增加样品制备和色谱分离的时间。